Title of article :
Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
Author/Authors :
Lancman, Guido Department of Medicine - Icahn School of Medicine at Mount Sinai, New York, NY, USA , steinberg, amir Tisch Cancer Institute -Mount Sinai Hospital, New York, NY, USA , Gabrilove, Janice Tisch Cancer Institute -Mount Sinai Hospital, New York, NY, USA
Abstract :
Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.
Keywords :
Serpentine supravenous hyperpigmentation , SSH , Chemotherapy , R- CHOP , DLBCL
Journal title :
Astroparticle Physics
